All Stories

  1. CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer

    Article • Epigenomics, October 2018, Future Medicine

    Ying-Cheng CHIANG

  2. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells

    Article • Endocrine Related Cancer, August 2018, Bioscientifica

    Ying-Cheng CHIANG

  3. Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation

    Article • Cancer Letters, July 2018, Elsevier

    Ying-Cheng CHIANG

  4. Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment

    Article • Molecular Therapy, February 2018, Elsevier

    Ying-Cheng CHIANG

  5. Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies

    Article • Frontiers in Pharmacology, November 2017, Frontiers

    Ying-Cheng CHIANG

  6. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study

    Article • Taiwanese Journal of Obstetrics and Gynecology, August 2017, Elsevier

    Ying-Cheng CHIANG

  7. Risk factors associated with failure of treatment for cesarean scar pregnancy

    Article • International Journal of Gynecology & Obstetrics, April 2017, Wiley

    Ying-Cheng CHIANG

  8. Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study

    Article • Journal of Gynecologic Oncology, January 2017, Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE)

    Ying-Cheng CHIANG

  9. Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup

    Article • Modern Pathology, June 2016, Springer Science + Business Media

    Ying-Cheng CHIANG

  10. Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma

    Article • Oncotarget, October 2015, Impact Journals, LLC

    Ying-Cheng CHIANG

  11. Outcome of patients with recurrent adult-type granulosa cell tumors – A Taiwanese Gynecologic Oncology Group study

    Article • Taiwanese Journal of Obstetrics and Gynecology, June 2015, Elsevier

    Ying-Cheng CHIANG

  12. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors

    Article • Journal of Magnetic Resonance Imaging, April 2015, Wiley

    Ying-Cheng CHIANG

  13. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression

    Article • Histopathology, December 2014, Wiley

    Ying-Cheng CHIANG

  14. Establishment of a New Ovarian Cancer Cell Line CA5171

    Article • Reproductive Sciences, November 2014, SAGE Publications

    Ying-Cheng CHIANG

  15. Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations

    Article • Human Pathology, November 2014, Elsevier

    Ying-Cheng CHIANG

  16. Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation

    Article • Modern Pathology, August 2014, Springer Science + Business Media

    Ying-Cheng CHIANG

  17. Impact of management on the prognosis of pure uterine papillary serous cancer — A Taiwanese Gynecologic Oncology Group (TGOG) study

    Article • Gynecologic Oncology, May 2014, Elsevier

    Ying-Cheng CHIANG

  18. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma

    Article • Modern Pathology, December 2013, Springer Science + Business Media

    Ying-Cheng CHIANG

  19. High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions

    Article • Taiwanese Journal of Obstetrics and Gynecology, June 2013, Elsevier

    Ying-Cheng CHIANG

  20. Sertoli–Leydig cell tumors of the ovary: A Taiwanese Gynecologic Oncology Group study

    Article • Taiwanese Journal of Obstetrics and Gynecology, March 2013, Elsevier

    Ying-Cheng CHIANG

  21. Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients

    Article • January 2013, Bioscientifica

    Ying-Cheng CHIANG

  22. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan

    Article • Journal of Gynecologic Oncology, January 2013, Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE)

    Ying-Cheng CHIANG

  23. Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects

    Article • Clinical Science, September 2012, Portland Press Ltd.

    Ying-Cheng CHIANG

  24. Brain metastases from epithelial ovarian carcinoma: Evaluation of prognosis and managements — A Taiwanese Gynecologic Oncology Group (TGOG) Study

    Article • Gynecologic Oncology, April 2012, Elsevier

    Ying-Cheng CHIANG

  25. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways

    Article • Biochemical Journal, March 2012, Portland Press Ltd.

    Ying-Cheng CHIANG

  26. New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation

    Article • Taiwanese Journal of Obstetrics and Gynecology, March 2012, Elsevier

    Ying-Cheng CHIANG

  27. A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors

    Article • Gynecologic Oncology, February 2012, Elsevier

    Ying-Cheng CHIANG

  28. Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response

    Article • Molecular Oncology, December 2011, Wiley

    Ying-Cheng CHIANG

  29. Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma

    Article • International Journal of Gynecology & Obstetrics, December 2010, Wiley

    Ying-Cheng CHIANG

  30. Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis

    Article • Molecular Therapy, June 2010, Elsevier

    Ying-Cheng CHIANG

  31. Tuberculosis peritonitis

    Article • Surgery, May 2006, Elsevier

    Ying-Cheng CHIANG

  32. Septic Shock after Conservative Management for Placenta Accreta

    Article • Taiwanese Journal of Obstetrics and Gynecology, March 2006, Elsevier

    Ying-Cheng CHIANG